CD44 expression in benign and malignant nevomelanocytic lesions. (Q50533788)

14 March 2018

title

CD44 expression in benign and malignant nevomelanocytic lesions. (English)

1 reference

14 March 2018

author name string

Leigh CJ

1

1 reference

14 March 2018

Palechek PL

2

1 reference

14 March 2018

Knutson JR

3

1 reference

14 March 2018

McCarthy JB

4

1 reference

14 March 2018

Cohen MB

5

1 reference

14 March 2018

Argenyi ZB

6

1 reference

14 March 2018

language of work or name

English

0 references

publication date

1 December 1996

1 reference

14 March 2018

published in

Human Pathology

1 reference

14 March 2018

volume

27

1 reference

14 March 2018

issue

12

1 reference

14 March 2018

page(s)

1288-1294

1 reference

14 March 2018

Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990339-1

7 January 2021

CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990339-1

7 January 2021

Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990339-1

7 January 2021

A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990339-1

7 January 2021

CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990339-1

7 January 2021

CD44H regulates tumor cell migration on hyaluronate-coated substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990339-1

7 January 2021

Immunohistological examination of the relationship between metastatic potential and expression of adhesion molecules and 'selectins' on melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990339-1

7 January 2021

Migration of human melanoma cells on hyaluronate is related to CD44 expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990339-1

7 January 2021

Identification of a polymorphism in human CD44

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990339-1

7 January 2021

Lymphocyte Migration into the Skin: The Role of Lymphocyte Homing Receptor (CD44) and Endothelial Cell Antigen (HECA-452)

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990339-1

7 January 2021

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990339-1

7 January 2021

CD44 is the principal cell surface receptor for hyaluronate

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990339-1

7 January 2021

CD44 and cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990339-1

7 January 2021

Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990339-1

7 January 2021

A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990339-1

7 January 2021

Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990339-1

7 January 2021

10.1016/S0046-8177(96)90339-1

Identifiers

DOI

1 reference

14 March 2018

1 reference

14 March 2018